With extensive experience in managing investments across various healthcare sectors, the fund manager has executed over 25 deals primarily in the biotechnology and medical device spaces. Active in both North American and European markets, their strategic style is characterized by a data-driven approach that emphasizes operational efficiency. Notable exits include several successful IPOs and acquisitions, demonstrating a strong ability to navigate different investment stages effectively. Their thematic focus aligns with emerging trends in patient care and technology integration, driving impactful growth in their portfolio.